Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms

被引：182
作者：
Abdel-Wahab, O. [1 ,2 ]
Pardanani, A. [3 ]
Patel, J. [1 ]
Wadleigh, M. [4 ]
Lasho, T. [3 ]
Heguy, A. [1 ]
Beran, M. [5 ]
Gilliland, D. G. [6 ]
Levine, R. L. [1 ,2 ]
Tefferi, A. [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Leukemia Serv, Dept Med, New York, NY 10021 USA
[3] Mayo Clin, Div Hematol, Rochester, MN USA
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[5] MD Anderson Canc, Div Leukemia, Houston, TX 77030 USA
[6] Merck & Co Inc, N Wales, PA USA
来源：
LEUKEMIA | 2011年 / 25卷 / 07期
关键词：
MYELOID-LEUKEMIA; GENE; PROGRESSION; TET2;
D O I：
10.1038/leu.2011.58
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1200 / 1202
页数：3
相关论文
共 8 条
  • [1] High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
    Boultwood, J.
    Perry, J.
    Zaman, R.
    Fernandez-Santamaria, C.
    Littlewood, T.
    Kusec, R.
    Pellagatti, A.
    Wang, L.
    Clark, R. E.
    Wainscoat, J. S.
    [J]. LEUKEMIA, 2010, 24 (06) : 1139 - 1145
  • [2] Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
    Carbuccia, N.
    Trouplin, V.
    Gelsi-Boyer, V.
    Murati, A.
    Rocquain, J.
    Adelaide, J.
    Olschwang, S.
    Xerri, L.
    Vey, N.
    Chaffanet, M.
    Birnbaum, D.
    Mozziconacci, M. J.
    [J]. LEUKEMIA, 2010, 24 (02) : 469 - 473
  • [3] Mutations of ASXL1 gene in myeloproliferative neoplasms
    Carbuccia, N.
    Murati, A.
    Trouplin, V.
    Brecqueville, M.
    Adelaide, J.
    Rey, J.
    Vainchenker, W.
    Bernard, O. A.
    Chaffanet, M.
    Vey, N.
    Birnbaum, D.
    Mozziconacci, M. J.
    [J]. LEUKEMIA, 2009, 23 (11) : 2183 - 2186
  • [4] Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
    Ernst, Thomas
    Chase, Andrew J.
    Score, Joannah
    Hidalgo-Curtis, Claire E.
    Bryant, Catherine
    Jones, Amy V.
    Waghorn, Katherine
    Zoi, Katerina
    Ross, Fiona M.
    Reiter, Andreas
    Hochhaus, Andreas
    Drexler, Hans G.
    Duncombe, Andrew
    Cervantes, Francisco
    Oscier, David
    Boultwood, Jacqueline
    Grand, Francis H.
    Cross, Nicholas C. P.
    [J]. NATURE GENETICS, 2010, 42 (08) : 722 - U109
  • [5] ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
    Gelsi-Boyer, Veronique
    Trouplin, Virginie
    Roquain, Julien
    Adelaide, Jose
    Carbuccia, Nadine
    Esterni, Benjamin
    Finetti, Pascal
    Murati, Anne
    Arnoulet, Christine
    Zerazhi, Hacene
    Fezoui, Hacene
    Tadrist, Zoulika
    Nezri, Meyer
    Chaffanet, Max
    Mozziconacci, Marie-Joeelle
    Vey, Norbert
    Birnbaum, Daniel
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (04) : 365 - 375
  • [6] Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis
    Passamonti, Francesco
    Cervantes, Francisco
    Vannucchi, Alessandro Maria
    Morra, Enrica
    Rumi, Elisa
    Cazzola, Mario
    Tefferi, Ayalew
    [J]. BLOOD, 2010, 116 (15) : 2857 - 2858
  • [7] Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia
    Perez, Benoite
    Kosmider, Olivier
    Cassinat, Bruno
    Renneville, Aline
    Lachenaud, Julie
    Kaltenbach, Sophie
    Bertrand, Yves
    Baruchel, Andre
    Chomienne, Christine
    Fontenay, Michaela
    Preudhomme, Claude
    Cave, Helene
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (05) : 460 - 468
  • [8] Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations
    Szpurka, Hadrian
    Jankowska, Anna M.
    Makishima, Hideki
    Bodo, Juraj
    Bejanyan, Nelli
    Hsi, Eric D.
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    [J]. LEUKEMIA RESEARCH, 2010, 34 (08) : 969 - 973
1